Today: 9 April 2026
Subscribe
Browse Category

Earnings Reports 12 January 2026

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity shares fell about 10% Monday after the company issued a cautious initial fiscal 2027 outlook, projecting revenue between $1.38 billion and $1.41 billion and an HSA cash yield near 3.75%. The stock last traded at $84.62, down $9.53. Executives will present at the J.P. Morgan Healthcare Conference on Tuesday. The company reaffirmed its 2026 guidance.
12 January 2026
··
Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

Texas Instruments shares slipped 0.2% to $189.85 in Monday afternoon trading, underperforming chip sector peers as the iShares Semiconductor ETF rose 0.7% and Nvidia gained about 1%. Investors are watching TI’s Jan. 27 earnings for signals on industrial and auto demand amid market volatility tied to a Justice Department probe involving Fed Chair Jerome Powell.
12 January 2026
····
Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

Lululemon shares rose 3.2% to $210.43 Monday after the company said holiday-quarter revenue and profit would reach the high end of its forecast, citing strong seasonal demand. The retailer maintained its margin and expense outlook. CEO Calvin McDonald steps down Jan. 31, with interim co-CEOs named as the board searches for a replacement. Founder Chip Wilson has launched a proxy fight as Elliott Management builds a $1 billion stake.
12 January 2026
··
Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell shares edged up 0.1% to $207.50 after launching new software tools for retail and warehouse operations. Citi lowered its price target to $262 but maintained a buy rating. Investors await Honeywell’s Jan. 29 results and 2026 outlook for signs of demand and margin trends. Honeywell will start rolling out its new Smart Shopping Platform in February.
12 January 2026
··
Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade shares jumped 7.7% to $85.81 Monday, hitting a new 52-week high amid heavy short interest and volatile trading. About 20% of the float was shorted as of mid-December, raising the risk of sharp moves. Chief insurance officer John Peters sold 10,000 shares Jan. 6 at $80 under a pre-set plan. The next earnings report is expected Feb. 24.
12 January 2026
··
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Johnson & Johnson shares rose 2.3% to $209.03 after new data showed its drug Rybrevant, combined with chemotherapy, produced a 51% response rate in metastatic colorectal cancer. The results, from the OrigAMI-1 trial, included a 73% response rate in first-line patients. The company’s fourth-quarter earnings report is due Jan. 21. J&J recently struck a deal with the Trump administration to lower U.S. drug prices.
12 January 2026
···
Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
12 January 2026
··
Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage stock jumps nearly 8% as investor focus turns to insider filing, CPI and a Needham webcast

Pure Storage shares rose 7.9% to $72.29 on Monday, outpacing the broader market. A Friday filing showed founder John Colgrove transferred 200,000 shares as gifts between family trusts. Investors are watching Tuesday’s U.S. CPI report and Pure’s presentation at the Needham Growth Conference on Thursday. Peer stocks, including NetApp and Western Digital, also advanced.
12 January 2026
···
Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares surged 6.7% to $48.73 in New York Monday after gold prices hit a record high, prompting gains across gold miners. The rally followed safe-haven buying and a weaker dollar ahead of Tuesday’s U.S. inflation report. Gold Fields earlier touched $49.58, with Newmont, AngloGold Ashanti, and Wheaton Precious Metals also advancing. Investors await CPI data for clues on rates and sector momentum.
12 January 2026
·······
Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results

Twist Bioscience shares rose nearly 8% Monday after preliminary fiscal Q1 revenue reached about $103.7 million, beating company forecasts. DNA Synthesis and Protein Solutions sales climbed 27% to $51.1 million, while NGS Applications revenue hit $52.6 million. CEO Emily Leproust cited strong demand in both segments. Full audited results are due Feb. 2.
12 January 2026
··
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
12 January 2026
···
Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify stock slips as Wall Street digests Fed pressure — CPI and earnings ahead for SPOT

Spotify shares fell 1.2% to $532.97 by midday Monday, underperforming a steady U.S. market as investors eyed political pressure on the Federal Reserve and looming inflation data. The S&P 500-tracking SPY ETF rose 0.1%. Attention is turning to Spotify’s quarterly report on February 10 for updates on subscription pricing and ad demand.
12 January 2026
···
Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum stock drops 5% in late morning trade as AI optics bets cool ahead of earnings

Lumentum Holdings shares fell 5.4% to $332.28 Monday, underperforming a flat U.S. market. The drop followed news that chief accounting officer Matthew Sepe will step down in early February, with Eric Chang set to replace him. Investors are awaiting Lumentum’s Feb. 3 earnings report and conference call. The stock touched an intraday low of $323.24.
12 January 2026
····
1 … 121 122 123 124 125 … 229

Stock Market Today

  • Dollar Drops to 4-Week Low as US-Iran Ceasefire Boosts Gold and Euro
    April 8, 2026, 6:02 PM EDT. The dollar index fell 0.71%, hitting a 4-week low after the US and Iran agreed to a ceasefire, reducing demand for the dollar as a safe haven. Equity markets rallied, further lowering dollar liquidity needs. Declining U.S. Treasury yields weakened the dollar by narrowing interest rate advantages. The March Federal Open Market Committee minutes were neutral, highlighting elevated inflation and employment risks amid Middle East tensions. Swaps markets assign just a 1% chance of a rate hike in the next FOMC meeting, with expectations of rate cuts in 2026. The euro rose 0.47% to a 5-week high, helped by a plunge in crude oil prices and a weaker dollar despite soft Eurozone economic data. The yen strengthened 0.57% against the dollar, supported by lower yields and stronger Japanese earnings data, though mixed economic signals capped gains.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Go toTop